In studies of typically developing adults with depression, ketamine induces brain changes detectable on EEG, including increased high frequency activity [15, 16], consistent with prior studies of the effect of low-dose ketamine on the brain in MECP2-null mice [6]. This evidence concerns the gene MECP2 and depressive symptom measurement.